Oramed Pharmaceuticals (ORMP) Non Operating Income (2009 - 2026)
Oramed Pharmaceuticals (ORMP) reported Non Operating Income of $103.74 million for Q2 2026, up 575.1% from $15.37 million a year earlier and up 131.3% from the prior quarter.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) Non Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Oramed Pharmaceuticals' Non Operating Income came in at $225.24 million; for FY2025, it came in at $89.45 million.
- Non Operating Income has a three-year compound annual growth rate of 212.4% (FY2022 to FY2025).
- By year, Non Operating Income came in at -$2.29 million in FY2024, $22.89 million in FY2023 (+680.3%) and $2.93 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income in data going back to Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $44.85 million (Q1 2026), $15.18 million (Q4 2025) and $61.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Oramed Pharmaceuticals | 164.02 Mn | -170.72 Mn | - | 103.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.74 Mn |
| Mar 31, 2026 | 44.85 Mn |
| Dec 31, 2025 | 15.18 Mn |
| Sep 30, 2025 | 61.47 Mn |
| Jun 30, 2025 | 15.37 Mn |
| Mar 31, 2025 | -2.56 Mn |
| Dec 31, 2024 | -6.19 Mn |
| Sep 30, 2024 | -15.42 Mn |
| Jun 30, 2024 | 14.23 Mn |
| Mar 31, 2024 | 5.09 Mn |
| Dec 31, 2023 | 18.38 Mn |
| Sep 30, 2023 | 435,000.00 |
| Jun 30, 2023 | 2.48 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 350,000.00 |
| Mar 31, 2022 | 544,000.00 |
| Nov 30, 2021 | -38,000.00 |
| Aug 31, 2021 | 203,000.00 |
API Access
Oramed Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();